Product logins

Find logins to all Clarivate products below.


๋ธ”๋กœ๊ทธ: Rare diseases

Here you will find relevant articles and insight into all Clarivate related products and news.

7๊ฐœ์˜ ADC ๊ธฐ์—…๋“ค์ด ๋‚œ์น˜์„ฑ ์•”์— ๋Œ€ํ•œ ์ƒˆ๋กœ์šด ๊ฐ€๋Šฅ์„ฑ์„ ๋ณด์—ฌ์ฃผ๋Š” ์น˜๋ฃŒ์ œ๋ฅผ ๊ฐœ๋ฐœํ•˜๊ณ  ์žˆ์Šต๋‹ˆ๋‹ค. 7๊ฐœ์˜ ADC ๊ธฐ์—…๋“ค์ด ๋‚œ์น˜์„ฑ ์•”์— ๋Œ€ํ•œ ์ƒˆ๋กœ์šด ๊ฐ€๋Šฅ์„ฑ์„ ๋ณด์—ฌ์ฃผ๋Š” ์น˜๋ฃŒ์ œ๋ฅผ ๊ฐœ๋ฐœํ•˜๊ณ  ์žˆ์Šต๋‹ˆ๋‹ค.
๋ธ”๋กœ๊ทธ 2024๋…„ 6์›” 19์ผ
7๊ฐœ์˜ ADC ๊ธฐ์—…๋“ค์ด ๋‚œ์น˜์„ฑ ์•”์— ๋Œ€ํ•œ ์ƒˆ๋กœ์šด ๊ฐ€๋Šฅ์„ฑ์„ ๋ณด์—ฌ์ฃผ๋Š” ์น˜๋ฃŒ์ œ๋ฅผ ๊ฐœ๋ฐœํ•˜๊ณ  ์žˆ์Šต๋‹ˆ๋‹ค.
ADC Clinical research Early drug development research
์ ์‘์ฆ ํ™•์žฅ: ๊ธฐ์กด ํ•ญ์•”์ œ์˜ ์ƒˆ๋กœ์šด ์‚ฌ์šฉ๋ฒ•์„ ๊ฐœ์ฒ™ํ•˜๋‹ค ์ ์‘์ฆ ํ™•์žฅ: ๊ธฐ์กด ํ•ญ์•”์ œ์˜ ์ƒˆ๋กœ์šด ์‚ฌ์šฉ๋ฒ•์„ ๊ฐœ์ฒ™ํ•˜๋‹ค
๋ธ”๋กœ๊ทธ 2024๋…„ 5์›” 31์ผ
์ ์‘์ฆ ํ™•์žฅ: ๊ธฐ์กด ํ•ญ์•”์ œ์˜ ์ƒˆ๋กœ์šด ์‚ฌ์šฉ๋ฒ•์„ ๊ฐœ์ฒ™ํ•˜๋‹ค
Clinical research Consulting Resource Center Early drug development research
์ƒ๋ช…๊ณผํ•™์‚ฐ์—…์—์„œ ์ธ๊ณต์ง€๋Šฅ ๋ฐ ๋จธ์‹ ๋Ÿฌ๋‹์˜ ์ž ์žฌ๋ ฅํ™œ์šฉํ•˜๊ธฐ ์ƒ๋ช…๊ณผํ•™์‚ฐ์—…์—์„œ ์ธ๊ณต์ง€๋Šฅ ๋ฐ ๋จธ์‹ ๋Ÿฌ๋‹์˜ ์ž ์žฌ๋ ฅํ™œ์šฉํ•˜๊ธฐ
๋ธ”๋กœ๊ทธ 2024๋…„ 2์›” 5์ผ
์ƒ๋ช…๊ณผํ•™์‚ฐ์—…์—์„œ ์ธ๊ณต์ง€๋Šฅ ๋ฐ ๋จธ์‹ ๋Ÿฌ๋‹์˜ ์ž ์žฌ๋ ฅํ™œ์šฉํ•˜๊ธฐ
Pharma Rare diseases ๋จธ์‹ ๋Ÿฌ๋‹
CMS(๋ณด๊ฑด์˜๋ฃŒ์žฌ์ •์ฒญ) ๊ฐ€๊ฒฉ ํ˜‘์ƒ ๋ฆฌ์ŠคํŠธ์— ์˜ค๋ฅธ 10๊ฐœ ์•ฝ๋ฌผ์— ๋Œ€ํ•œ 5๊ฐ€์ง€ ํฌ์ธํŠธ CMS(๋ณด๊ฑด์˜๋ฃŒ์žฌ์ •์ฒญ) ๊ฐ€๊ฒฉ ํ˜‘์ƒ ๋ฆฌ์ŠคํŠธ์— ์˜ค๋ฅธ 10๊ฐœ ์•ฝ๋ฌผ์— ๋Œ€ํ•œ 5๊ฐ€์ง€ ํฌ์ธํŠธ
๋ธ”๋กœ๊ทธ 2023๋…„ 10์›” 25์ผ
CMS(๋ณด๊ฑด์˜๋ฃŒ์žฌ์ •์ฒญ) ๊ฐ€๊ฒฉ ํ˜‘์ƒ ๋ฆฌ์ŠคํŠธ์— ์˜ค๋ฅธ 10๊ฐœ ์•ฝ๋ฌผ์— ๋Œ€ํ•œ 5๊ฐ€์ง€ ํฌ์ธํŠธ
Oncology Pharma Portfolio strategy

Rare diseases

7๊ฐœ์˜ ADC ๊ธฐ์—…๋“ค์ด ๋‚œ์น˜์„ฑ ์•”์— ๋Œ€ํ•œ ์ƒˆ๋กœ์šด ๊ฐ€๋Šฅ์„ฑ์„ ๋ณด์—ฌ์ฃผ๋Š” ์น˜๋ฃŒ์ œ๋ฅผ ๊ฐœ๋ฐœํ•˜๊ณ  ์žˆ์Šต๋‹ˆ๋‹ค. 7๊ฐœ์˜ ADC ๊ธฐ์—…๋“ค์ด ๋‚œ์น˜์„ฑ ์•”์— ๋Œ€ํ•œ ์ƒˆ๋กœ์šด ๊ฐ€๋Šฅ์„ฑ์„ ๋ณด์—ฌ์ฃผ๋Š” ์น˜๋ฃŒ์ œ๋ฅผ ๊ฐœ๋ฐœํ•˜๊ณ  ์žˆ์Šต๋‹ˆ๋‹ค.
๋ธ”๋กœ๊ทธ 2024๋…„ 6์›” 19์ผ
7๊ฐœ์˜ ADC ๊ธฐ์—…๋“ค์ด ๋‚œ์น˜์„ฑ ์•”์— ๋Œ€ํ•œ ์ƒˆ๋กœ์šด ๊ฐ€๋Šฅ์„ฑ์„ ๋ณด์—ฌ์ฃผ๋Š” ์น˜๋ฃŒ์ œ๋ฅผ ๊ฐœ๋ฐœํ•˜๊ณ  ์žˆ์Šต๋‹ˆ๋‹ค.
์ ์‘์ฆ ํ™•์žฅ: ๊ธฐ์กด ํ•ญ์•”์ œ์˜ ์ƒˆ๋กœ์šด ์‚ฌ์šฉ๋ฒ•์„ ๊ฐœ์ฒ™ํ•˜๋‹ค ์ ์‘์ฆ ํ™•์žฅ: ๊ธฐ์กด ํ•ญ์•”์ œ์˜ ์ƒˆ๋กœ์šด ์‚ฌ์šฉ๋ฒ•์„ ๊ฐœ์ฒ™ํ•˜๋‹ค
๋ธ”๋กœ๊ทธ 2024๋…„ 5์›” 31์ผ
์ ์‘์ฆ ํ™•์žฅ: ๊ธฐ์กด ํ•ญ์•”์ œ์˜ ์ƒˆ๋กœ์šด ์‚ฌ์šฉ๋ฒ•์„ ๊ฐœ์ฒ™ํ•˜๋‹ค
์ƒ๋ช…๊ณผํ•™์‚ฐ์—…์—์„œ ์ธ๊ณต์ง€๋Šฅ ๋ฐ ๋จธ์‹ ๋Ÿฌ๋‹์˜ ์ž ์žฌ๋ ฅํ™œ์šฉํ•˜๊ธฐ ์ƒ๋ช…๊ณผํ•™์‚ฐ์—…์—์„œ ์ธ๊ณต์ง€๋Šฅ ๋ฐ ๋จธ์‹ ๋Ÿฌ๋‹์˜ ์ž ์žฌ๋ ฅํ™œ์šฉํ•˜๊ธฐ
๋ธ”๋กœ๊ทธ 2024๋…„ 2์›” 5์ผ
์ƒ๋ช…๊ณผํ•™์‚ฐ์—…์—์„œ ์ธ๊ณต์ง€๋Šฅ ๋ฐ ๋จธ์‹ ๋Ÿฌ๋‹์˜ ์ž ์žฌ๋ ฅํ™œ์šฉํ•˜๊ธฐ
CMS(๋ณด๊ฑด์˜๋ฃŒ์žฌ์ •์ฒญ) ๊ฐ€๊ฒฉ ํ˜‘์ƒ ๋ฆฌ์ŠคํŠธ์— ์˜ค๋ฅธ 10๊ฐœ ์•ฝ๋ฌผ์— ๋Œ€ํ•œ 5๊ฐ€์ง€ ํฌ์ธํŠธ CMS(๋ณด๊ฑด์˜๋ฃŒ์žฌ์ •์ฒญ) ๊ฐ€๊ฒฉ ํ˜‘์ƒ ๋ฆฌ์ŠคํŠธ์— ์˜ค๋ฅธ 10๊ฐœ ์•ฝ๋ฌผ์— ๋Œ€ํ•œ 5๊ฐ€์ง€ ํฌ์ธํŠธ
๋ธ”๋กœ๊ทธ 2023๋…„ 10์›” 25์ผ
CMS(๋ณด๊ฑด์˜๋ฃŒ์žฌ์ •์ฒญ) ๊ฐ€๊ฒฉ ํ˜‘์ƒ ๋ฆฌ์ŠคํŠธ์— ์˜ค๋ฅธ 10๊ฐœ ์•ฝ๋ฌผ์— ๋Œ€ํ•œ 5๊ฐ€์ง€ ํฌ์ธํŠธ